JUNIPER PHARMACEUTICALS INC's ticker is JNP and the CUSIP is 48203L107. A total of 53 filers reported holding JUNIPER PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $3,525,000 | -11.4% | 405,196 | +3.4% | 0.00% | – |
| Q1 2018 | $3,978,000 | +125.6% | 391,902 | +7.8% | 0.00% | – |
| Q4 2017 | $1,763,000 | +8.0% | 363,463 | +1.3% | 0.00% | – |
| Q3 2017 | $1,633,000 | -14.4% | 358,923 | -4.9% | 0.00% | – |
| Q2 2017 | $1,907,000 | -11.1% | 377,501 | -16.4% | 0.00% | – |
| Q1 2017 | $2,144,000 | -14.8% | 451,338 | +0.4% | 0.00% | – |
| Q4 2016 | $2,517,000 | +1.0% | 449,396 | +0.0% | 0.00% | – |
| Q3 2016 | $2,493,000 | -18.4% | 449,196 | +3.1% | 0.00% | – |
| Q2 2016 | $3,054,000 | +6.7% | 435,627 | +0.6% | 0.00% | – |
| Q1 2016 | $2,863,000 | -26.5% | 433,039 | +14.6% | 0.00% | – |
| Q4 2015 | $3,893,000 | -54.0% | 377,902 | -47.5% | 0.00% | – |
| Q3 2015 | $8,472,000 | +200.7% | 719,220 | +133.6% | 0.00% | – |
| Q2 2015 | $2,817,000 | – | 307,895 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 388,132 | $1,844,000 | 0.38% |
| Krensavage Asset Management, LLC | 243,128 | $1,155,000 | 0.37% |
| ALGERT GLOBAL LLC | 108,315 | $514,000 | 0.14% |
| HEARTLAND ADVISORS INC | 400,000 | $1,900,000 | 0.12% |
| AWM Investment Company, Inc. | 200,000 | $950,000 | 0.09% |
| TFS CAPITAL LLC | 31,619 | $150,000 | 0.05% |
| GLOBEFLEX CAPITAL L P | 20,012 | $95,000 | 0.02% |
| Spark Investment Management LLC | 45,100 | $214,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 180,200 | $856,000 | 0.01% |
| Acrospire Investment Management LLC | 1,605 | $8,000 | 0.01% |